Published Resources
Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy
Professor Zoe McQuilten
15th November 2023
Findings from the randomized controlled RATIONAL feasibility trial which supported the initiation of a larger phase 3 clinical trial
Immunoglobulin use, survival, and infection outcomes in patients with chronic lymphocytic leukemia
Dr Sara Carrillo de Albornoz
28th October 2025
Variation in immunoglobulin use and impact on survival in myeloma
Dr Khai Li Chai
16th June 2024
This study investigated immunoglobulin use in Australia, New Zealand and Asia-Pacific using registry data of MM patients and exploring the association with survival outcomes.
Trial Documents
RATIONAL Platform Trial summary page
A summary document explaining the key concepts of the trial and covering some frequently asked questions
